- Home
- VSAT vs IMTX Comparison
VSAT vs IMTX Comparison
Compare VSAT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSAT
- IMTX
- Stock Information
- Founded
- VSAT 1986
- IMTX N/A
- Country
- VSAT United States
- IMTX Germany
- Employees
- VSAT N/A
- IMTX N/A
- Industry
- VSAT Radio And Television Broadcasting And Communications Equipment
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSAT Technology
- IMTX Health Care
- Exchange
- VSAT Nasdaq
- IMTX Nasdaq
- Market Cap
- VSAT 1.1B
- IMTX 954.2M
- IPO Year
- VSAT 1996
- IMTX N/A
- Fundamental
- Price
- VSAT $9.30
- IMTX $7.08
- Analyst Decision
- VSAT Buy
- IMTX Strong Buy
- Analyst Count
- VSAT 7
- IMTX 4
- Target Price
- VSAT $19.00
- IMTX $16.67
- AVG Volume (30 Days)
- VSAT 3.4M
- IMTX 522.7K
- Earning Date
- VSAT 02-04-2025
- IMTX 11-18-2024
- Dividend Yield
- VSAT N/A
- IMTX N/A
- EPS Growth
- VSAT N/A
- IMTX N/A
- EPS
- VSAT N/A
- IMTX N/A
- Revenue
- VSAT $4,527,274,000.00
- IMTX $128,824,447.00
- Revenue This Year
- VSAT $7.71
- IMTX $90.79
- Revenue Next Year
- VSAT $1.73
- IMTX N/A
- P/E Ratio
- VSAT N/A
- IMTX N/A
- Revenue Growth
- VSAT 36.25
- IMTX 52.53
- 52 Week Low
- VSAT $6.69
- IMTX $6.99
- 52 Week High
- VSAT $29.11
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- VSAT 49.19
- IMTX 27.93
- Support Level
- VSAT $8.95
- IMTX $6.99
- Resistance Level
- VSAT $9.76
- IMTX $7.40
- Average True Range (ATR)
- VSAT 0.76
- IMTX 0.30
- MACD
- VSAT 0.07
- IMTX -0.00
- Stochastic Oscillator
- VSAT 34.97
- IMTX 10.46
About VSAT ViaSat Inc.
Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.